Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapy
2020 ◽
Vol 31
(9)
◽
pp. 1186-1197
◽